American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease von Lichtenstein, Gary R., Abreu, Maria T., Cohen, Russell, Tremaine, William

Volltext

Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry von Lichtenstein, Gary R., Feagan, Brian G., Cohen, Russell D., Salzberg, Bruce A., Diamond, Robert H., Chen, Donny M., Pritchard, Michelle L., Sandborn, William J.

Volltext

Review article: monitoring of immunomodulators in inflammatory bowel disease von Aberra, F. N., Lichtenstein, G. R.

Volltext

Integrating anti–tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives von Blam, Michael E, Stein, Robert B, Lichtenstein, Gary R

Volltext

Complications of biological therapy for inflammatory bowel diseases von Blonski, Wojciech, Lichtenstein, Gary R

Volltext

A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease von Kotlyar, David S, Osterman, Mark T, Diamond, Robert H, Porter, David, Blonski, Wojciech C, Wasik, Mariusz, Sampat, Sami, Mendizabal, Manuel, Lin, Ming V, Lichtenstein, Gary R

Volltext

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis von Rutgeerts, Paul, Sandborn, William J, Feagan, Brian G, Reinisch, Walter, Olson, Allan, Johanns, Jewel, Travers, Suzanne, Rachmilewitz, Daniel, Hanauer, Stephen B, Lichtenstein, Gary R, de Villiers, Willem J.S, Present, Daniel, Sands, Bruce E, Colombel, Jean Frédéric

Volltext

Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn’s disease von Lichtenstein, Gary R., Yan, Songkai, Bala, Mohan, Blank, Marion, Sands, Bruce E.

Volltext

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study von Allegretti, Jessica R., Rubin, David T., Germinaro, Matthew, Huang, Kuan-Hsiang (Gary), Shipitofsky, Nicole, Wilson, Rebbecca, Han, Chenglong, Feagan, Brian G., Sandborn, William J., Panés, Julian, Hisamatsu, Tadakazu, Lichtenstein, Gary R., Dignass, Axel, Afanasieva, Halyna, Aitova, Lilia, Altintas, Engin, Altwegg, Romain, Andreev, Pavel, Aomatsu, Kazuki, Balestrieri, Paola, Brunatto, Luciana, Bulgheroni, Diego, Cabello, Mercedes, Cao, Qian, Caprioli, Flavio, Cerqueira, Rute, Chiu, Cheng-Tang, Choi, Chang Hwan, Dewint, Pieter, Dutré, Joris, Duvall, George, Fernandez, Juan, Filip, Rafal, Fogel, Ronald, Fowler, Sharyle, Fujii, Toshimitsu, Fukata, Masayuki, Furumoto, Yohei, Gasbarrini, Antonio, Gionchetti, Paolo, Goldin, Eran, Gonciarz, Maciej, Gonen, Can, Gyokeres, Tibor, Hébuterne, Xavier, Hellström, Per, Horný, Ivo, Hoshi, Namiko, Hrdlicka, Ludek, Ishihara, Shunji, Jang, Byung Ik, Kagaya, Takashi, Kanmura, Shuji, Katsuhiko, Nakai, Kiss, Gyula G., Klaus, Jochen, Kleczkowski, Dariusz, Klopocka, Maria, Kopon, Adam, Kravchenko, Tetiana, Kwon, Kwang An, Lago, Paula, Leszczyszyn, Jaroslaw, Marusawa, Hiroyuki, Miyabayashi, Hideharu, Mohl, Wolfgang, Motoya, Satoshi, Murali, Narayanachar, Nakajima, Koichi, Nakamoto, Yasunari, Nancey, Stéphane, Neto, Joaquim, Onizawa, Michio, Ono, Yohei, Osipenko, Marina, Patel, Bhaktasharan, Petrova, Elina, Poroshina, Elena, Prystupa, Lyudmyla, Roblin, Xavier, Romatowski, Jacek, Sakuraba, Hirotake, Schulze, Joerg, Shin, Sung Jae, Stanislavchuk, Mykola, Stokesberry, David, Suzuki, Takayoshi, Taguchi, Hiroki, Thin, Lena, Torrealba, Leyanira, Tsarynna, Nataliia, Tulassay, Zsolt, Ueo, Tetsuya, Valuyskikh, Ekaterina, Wei, Shu-Chen, Weisshof, Roni, Wojcik, Katarzyna, Yoshida, Kosuke, Zaha, Osamu, Zhan, Qiang

Volltext

Association of 6-Thioguanine Nucleotide Levels and Inflammatory Bowel Disease Activity: A Meta-Analysis von Osterman, Mark T., Kundu, Rabi, Lichtenstein, Gary R., Lewis, James D.

Volltext

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease von Rutgeerts, Paul, Feagan, Brian G., Lichtenstein, Gary R., Mayer, Lloyd F., Schreiber, Stefan, Colombel, Jean Frederic, Rachmilewitz, Daniel, Wolf, Douglas C., Olson, Allan, Bao, Weihang, Hanauer, Stephen B.

Volltext

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease von Rutgeerts, Paul, MD, PhD, Diamond, Robert H., MD, Bala, Mohan, PhD, Olson, Allan, MD, Lichtenstein, Gary, MD, Bao, Weihang, PhD, Patel, Kamlesh, MS, Wolf, Douglas C., MD, Safdi, Michael, MD, Colombel, Jean Frederic, MD, Lashner, Bret, MD, Hanauer, Stephen B., MD

Volltext

Infliximab use in Crohn's disease von Bewtra, Meenakshi, Lichtenstein, Gary R

Volltext

New ACG Guideline for the Management of Crohn's Disease von Lichtenstein, Gary R

Volltext

Is infliximab effective for induction of remission in patients with ulcerative colitis? von Lichtenstein, G R

Volltext

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial von Hanauer, Stephen B, Feagan, Brian G, Lichtenstein, Gary R, Mayer, Lloyd F, Schreiber, S, Colombel, Jean Frederic, Rachmilewitz, Daniel, Wolf, Douglas C, Olson, Allan, Bao, Weihang, Rutgeerts, Paul

Volltext

Highlights From the New ACG Guideline on Crohn's Disease Management von Lichtenstein, Gary R

Volltext

The Impact of Increased Body Mass Index on the Clinical Course of Crohn’s Disease von Hass, David J., Brensinger, Colleen M., Lewis, James D., Lichtenstein, Gary R.

Volltext

Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients von Aberra, Faten N, Lewis, James D, Hass, David, Rombeau, John L, Osborne, Benjamin, Lichtenstein, Gary R

Volltext

Treatment of ulcerative colitis von Blonski, Wojciech, Buchner, Anna M, Lichtenstein, Gary R

Volltext